New method for phosphate kinetics estimation during hemodialysis and on-line hemodiafiltration with endogenous reinfusion

Blood Purification

Volumn 24, Issue 3, 2006, Pages 301-308

  Bolasco, P ^a   Ghezzi, P M ^b   Ferrara, R ^c   Cogoni, G ^d   Cadinu, F ^e   Casu, D ^f   Murtas, S ^a  

^a Unit Nephrology and Dialysis   (Italy)

^b Unita Operativa di Nefrologia e Dialisi   (Italy)

^c SS Trinit Hospital   (Italy)

^d San Martino Hospital   (Italy)

^e SAN FRANCESCO HOSPITAL   (Italy)

^f Civil Hospital   (Italy)

Author keywords

Hemodiafiltration; Hemodialysis; Phosphates; Pseudohyperphosphatemia; Sorbents

Indexed keywords

AMMONIUM MOLYBDATE; MOLYBDIC ACID; PHOSPHATE; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG; UREA;

ACCURACY; ADSORPTION; ADULT; AGED; ARTICLE; AUTOMATION; CLINICAL ARTICLE; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; MALE; METHODOLOGY; PHOSPHATE METABOLISM; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; ULTRAFILTRATION;

FEMALE; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HUMANS; KINETICS; MALE; MIDDLE AGED; PHOSPHATES; RENAL DIALYSIS; TIME FACTORS; UREMIA;

EID: 33744466796     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091451     Document Type: Article

References (38)

1. Ratanarat R, Brendolan A, Volker G, et al: Phosphate kinetics during different dialysis modalities. Blood Purif 2005;23:83-90.
2. Pohlmeier R, Vienken J: Phosphate removal and hemodialysis conditions. Kidney Int 2001;(suppl 78):S190-S194.
3. Delrnez JA, Slatopolsky E: Hyperphosphatemia: its consequences and treatment in patient with chronic renal disease. Am J Kidney Dis 1992;19:303-317.
4. Block GA, Hulbert-Shearon TE, Levin NW, et al: Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patient: a national study. Am J Kidney Dis 1998;31:607-617.
5. Alfrey AC: The role of abnormal phosphorus metabolism in the progression of chronic kidney disease and metastatic calcification. Kidney Int 2004;(suppl 90):S13-S17.
6. Gutzwiller JP, Schneditz D, Huber AR, et al: Increasing blood flow increases Kt/V (urea) and potassium removal but fails to improve phosphate removal. Clin Nephrol 2003;59: 130-136.
7. Hsu CH: Are we mismanaging calcium and phosphate metabolism in renal failure? Am J Kidney Dis 1997;29:641-649.
8. Brenner B: Brenner & Rectors - The Kidney, ed 3. Philadelphia, Saunders, 1991.
9. Spalding EM, Chamney PW, Farrington K: Phosphate kinetics during hemodialysis: evidence for biphasic regulation. Kidney Int 2002;61:655-667.
10. Zehnder C, Gutzwiller JP, Renggli K: Hemodiafiltration: a new treatment option for hyperphosphatemia in hemodialysis patient. Clin Nephrol 1999;52:152-159.
11. Block G: How should hyperphosphatemia be managed in dialysis patients? Semin Dialysis 2002;15:315-317.
12. Zaman Z, Sneyers L, Van Orshoven A. et al: Elimination of paraprotein interference in determination of plasma inorganic phosphate by ammonium molybdate method. Clin Chem 1995;41:609-614.
13. Barutcuoglu B, Parildar Z, Mutaf I, et al: Spuriously elevated inorganic phosphate level in a multiple myeloma patient. Clin Lab Haematol 2003;25:271-274.
14. Cohen AM, Magazanik A, Van-der Liin E, et al: Pseudohyperphosphatemia incidence in an automatic analyzer. Eur J Clin Chem Clin Biochem 1994;32:559-561.
15. Larner AJ: Pseudohyperphosphatemia. Clin Biochem 1995;28:391-393.
16. Henderson LW, Colton CK, Ford CA: Kinetics of hemodiafiltration: clinical characterization of a new blood cleansing modality. J Lab Clin Med 1975;85:372-391.
17. Kunitomo T, Lowrie EG, Kumazawa S, O'Brien N, Lazarus JM, Gottlieb MN, Merrill JP: Controlled ultrafiltration with hemodialysis: analysis of coupling between convective and diffusive mass transfer in a new HD-UF system. Trans Am Soc Artif Intern Organs 1977;23:234-243.
18. Ghezzi PM, Frigato G, Fantini GF, et al: Theoretical model and first clinical results of the paired filtration dialysis (PFD). Life Support Syst 1983;1(suppl 1):271-274.
19. Ghezzi PM, Zucchelli P, Ringoir S, et al: Paired Filtration Dialysis (PFD): a separate convective-diffusive system for extracorporeal blood purification in uremic patients. Adv Exp Med Biol 1987;223:267-275.
20. Ghezzi PM, Gervasio R, Tessore V, et al: Hemodiafiltration without replacement fluid: experimental study. Trans Am Soc Artif Intern Organs 1992;38:61-65.
21. De Francisco ALM, Botella J, Escallada R, et al: Hemodiafiltration with sorbent-regenerated ultrafiltrate as replacement fluid: a multicenter study. Nephrol Dial Transplant 1997:12:528-534.
22. Botella J, Ghezzi PM, Sanz-Moreno C: Adsorption in hemodialysis. Kidney Int 2000;76:S60-S65.
23. Aucella F, Scalzulli RP, Vigilante M, Stallone C: The hemodiafiltration with endogenous reinfusion reduces the erythroid progenitor inhibition by uremic serum. Giorn It Nefrol 2004; 21(suppl 30):S128-S132.
24. De Nitti C, Giordano R, Gervasio R, et al: Choosing new adsorbents for endogenous ultrapure infusion fluid: performances, safety and flow distribution. Int J Artif Organs 2001;24:765-776.
25. Steuer RR, Miller DR, Zhang S, et al: Non invasive transcutaneous determination of access blood flow rate. Kidney Int 2001;60:284-291.
26. Dryer RL, Tammes AR, Routh JI: The determination of phosphorus and phosphatase with N-phenyl-p-phenylendiamine. J Biol Chem 1957;225:177-183.
27. Gotch FA, Panlilio F, Sergeyva O, et al: Effective diffusion volume flow rates (Qe) for urea, creatinine. and inorganic phosphorus (Qeu, Qecr, Qeip) during hemodialysis. Semin Dialysis 2003;16:474-476.
28. Messa P, Gropuzzo M, Cleva M, et al: Behaviour of phosphate removal with different dialysis schedules. Nephrol Dial Transplant 1998; 13(suppl 6):43-48.
29. Gotch FA, Froilan F, Sergeyeva O, et al: A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy. Blood Purif 2003;21:51-57.
30. Minutolo R, Bellizzi V, Cioffi M, Iodice C, Giannattasio P, Andreucci M, Terraciano V, Di Iorio BR, Conte G, De Nicola I: Postdialytic rebound of serum phosphorus: pathogenic and clinical insights. J Am Soc Nephrol 2002;13:1046-1054.
31. Smith I, Lowrie EG, Gottlieb MN, et al: The estimation of blood flow to hemodialyzers by bubble time. Proc Clin Dial Transplant Forum 1976;6:115-119.
32. Sands J, Lidden D, Jacavage W, Jones B: Difference between delivered and prescribed blood flow in hemodialysis. ASAIO J 1996;42:M717-M719.
33. Magnasco A, Bacchini G, Cappello A, et al: Clinical validation of glucose pump test (GPT) compared with ultrasound dilution technology in arteriovenous graft surveillance. Nephrol Dial Transplant 2004:19:1835-1841.
34. Krivitiski NM, MacGibbon D, Gleed RD, Dobson A: Accuracy of dilution techniques for access flow measurement during hemodialysis. Am J Kidney Dis 1998:31:502-508.
35. Gutzwiller JP, Schneditz D, Huber AR, et al: Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose. Nephrol Dial Transplant 2002:17:1037-1044.
36. Suchin EJ, Cizman B, Connolly BR, et al: Pseudohyperphosphatemia in a hyperphosphatemic hemodialysis patient. Am J Kidney Dis 2002;40:E18.
37. Costantini S, Meschini R, Meschini L, et al: Hemodiafiltration with endogenous reinfusion (HFR): biochemical and gas-analytical analysis of the 'regenerated' ultrafiltrate. Giorn It Nefrol 2004;21(suppl 30):S75-S79.
38. De Francisco ALM, Ghezzi PM, Brendolan A, et al: Hemodiafiltration with on line regeneration of the ultrafiltrate. Kidney Int 2000;(suppl 76):S66-S71.